Ralf Wagner

8.0k total citations
160 papers, 5.2k citations indexed

About

Ralf Wagner is a scholar working on Virology, Molecular Biology and Immunology. According to data from OpenAlex, Ralf Wagner has authored 160 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Virology, 81 papers in Molecular Biology and 64 papers in Immunology. Recurrent topics in Ralf Wagner's work include HIV Research and Treatment (84 papers), Immunotherapy and Immune Responses (35 papers) and Immune Cell Function and Interaction (31 papers). Ralf Wagner is often cited by papers focused on HIV Research and Treatment (84 papers), Immunotherapy and Immune Responses (35 papers) and Immune Cell Function and Interaction (31 papers). Ralf Wagner collaborates with scholars based in Germany, United States and Switzerland. Ralf Wagner's co-authors include Hans Wolf, Christine Ludwig, Marcus Graf, Ludwig Deml, Frank Notka, Kurt Bieler, David Peterhoff, Michael A. Liss, Josef Köstler and Jens Wild and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Ralf Wagner

155 papers receiving 5.1k citations

Peers

Countries citing papers authored by Ralf Wagner

Since Specialization

Citations

This map shows the geographic impact of Ralf Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Wagner more than expected).

Fields of papers citing papers by Ralf Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralf Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Wagner. The network helps show where Ralf Wagner may publish in the future.

Co-authorship network of co-authors of Ralf Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Ralf Wagner. A scholar is included among the top collaborators of Ralf Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralf Wagner. Ralf Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Multi-Faceted Binding Assessment of Aptamers Targeting the SARS-CoV-2 Spike Protein 2024 ·International Journal of Molecular Sciences ·Laia Civit, (unknown), (unknown), (unknown), Benedikt Asbach, David Peterhoff, Ralf Wagner, Michael Famulok, Günter Mayer, Jørgen Kjems, Julián Valero	3
2	Human Ad19a/64 HERV-W Vaccines Uncover Immunosuppression Domain-Dependent T-Cell Response Differences in Inbred Mice 2023 ·International Journal of Molecular Sciences ·(unknown), Emeline Ragonnaud, (unknown), Anne‐Marie Andersson, (unknown), (unknown), Louise Turner, Christian Thirion, Ralf Wagner, Peter Johannes Holst	4
3	Potency and durability of T and B cell immune responses after homologous and heterologous vector delivery of a trimer-stabilized, membrane-displayed HIV-1 clade ConC Env protein 2023 ·Frontiers in Immunology ·Beatriz Perdiguero, (unknown), Carmen Gómez, David Peterhoff, (unknown), Carlos Óscar S. Sorzano, (unknown), (unknown), (unknown), Benedikt Asbach, S.-W Ding, Dorotheé von Laer, Yves Lévy, Giuseppe Pantaleo, Janine Kimpel, Mariano Estéban, Ralf Wagner	1
4	Efficacy and Synergy with Cisplatin of an Adenovirus Vectored Therapeutic E1E2E6E7 Vaccine against HPV Genome–Positive C3 Cancers in Mice 2022 ·Cancer Immunology Research ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Christian Thirion, Benedikt Asbach, Ralf Wagner, Peter Johannes Holst	9
5	Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery 2021 ·Vaccines ·David Peterhoff, (unknown), Jan M. Sobczak, Mona O. Mohsen, (unknown), Nicole Seifert, (unknown), (unknown), S.-W Ding, Quentin J. Sattentau, Martin F. Bachmann, Miriam Breunig, Ralf Wagner	11
6	Stepwise Conformational Stabilization of a HIV-1 Clade C Consensus Envelope Trimer Immunogen Impacts the Profile of Vaccine-Induced Antibody Responses 2021 ·Vaccines ·(unknown), George Carnell, Kathrin Held, Guidenn Sulbarán, (unknown), (unknown), Georgios Pollakis, Paul Tonks, Michael Höelscher, S.-W Ding, Rogier W. Sanders, Christof Geldmacher, Quentin J. Sattentau, Winfríed Weissenhorn, Jonathan L. Heeney, David Peterhoff, Ralf Wagner	9
7	Expectations Regarding Dental Practice: A Cross-Sectional Survey of European Dental Students 2020 ·International Journal of Environmental Research and Public Health ·Thomas Gerhard Wolf, Ralf Wagner, (unknown), (unknown), (unknown), (unknown), Guglielmo Campus	4
8	Analysis of modular bioengineered antimicrobial lanthipeptides at nanoliter scale 2019 ·Nature Chemical Biology ·Steven Schmitt, Manuel Montalbán‐López, David Peterhoff, Jingjing Deng, Ralf Wagner, Martin Held, Oscar P. Kuipers, Sven Panke	91
9	Brk/Protein Tyrosine Kinase 6 Phosphorylates p27 ^KIP1 , Regulating the Activity of Cyclin D–Cyclin-Dependent Kinase 4 2015 ·Molecular and Cellular Biology ·(unknown), Benedikt Asbach, (unknown), (unknown), Alexander Coltoff, (unknown), Angela L. Tyner, Ralf Wagner, Stacy W. Blain	35
10	Systems Analysis of MVA-C Induced Immune Response Reveals Its Significance as a Vaccine Candidate against HIV/AIDS of Clade C 2012 ·PLoS ONE ·Carmen Gómez, Beatriz Perdiguero, Victoria Jiménez, Abdelali Filali‐Mouhim, Khader Ghneim, Elias K. Haddad, (unknown), Julie Delaloye, Alexandre Harari, Thierry Roger, (unknown), Rafick‐Pierre Sékaly, Cornelis J.M. Melief, Thierry Calandra, Federica Sallusto, Antonio Lanzavecchia, Ralf Wagner, Giuseppe Pantaleo, Mariano Estéban	20
11	Gene optimization mechanisms: A multi‐gene study reveals a high success rate of full‐length human proteins expressed in Escherichia coli 2010 ·Protein Science ·Barbara Maertens, Anne Spriestersbach, Uritza von Groll, Udo Roth, Jan Kubíček, Michael Gerrits, Marcus Graf, Michael A. Liss, (unknown), Ralf Wagner, Frank Schäfer	77
12	Comparison of Human and Rhesus Macaque T-Cell Responses Elicited by Boosting with NYVAC Encoding Human Immunodeficiency Virus Type 1 Clade C Immunogens 2009 ·Journal of Virology ·Petra Mooij, Sunita S. Balla-Jhagjhoorsingh, (unknown), (unknown), (unknown), Ivonne G. Nieuwenhuis, Shirin Heidari, Hans Wolf, Marie-Joëlle Frachette, Kurt Bieler, Neil C. Sheppard, Alexandre Harari, Pierre‐Alexandre Bart, Peter Liljeström, Ralf Wagner, Giuseppe Pantaleo, Jonathan L. Heeney	23
13	Preclinical Evaluation of the Immunogenicity of C-Type HIV-1-Based DNA and NYVAC Vaccines in the Balb/C Mouse Model 2009 ·Viral Immunology ·Jens Wild, Kurt Bieler, Josef Köstler, Marie-Joëlle Frachette, S. A. Jeffs, S. Vieǐra, Mariano Estéban, Peter Liljeström, Guiseppe Pantaleo, Hans Wolf, Ralf Wagner	19
14	Human immunodeficiency virus type-1 (HIV-1) Pr55gag virus-like particles are potent activators of human monocytes 2008 ·Virology ·Cornelia Speth, (unknown), (unknown), Jens Wild, Manfred P. Dierich, Hans Wolf, Josef Schroeder, Ralf Wagner, Ludwig Deml	11
15	Better Protective Effects in Rhesus Macaques by Combining Systemic and Mucosal Application of a Dual Component Vector Vaccine After Rectal SHIV89.6P Challenge Compared to Systemic Vaccination Alone 2008 ·Viral Immunology ·(unknown), Kurt Bieler, Josef Köstler, Jonathan L. Heeney, Peter ten Haaft, (unknown), Gerhard Hunsmann, Christiane Stahl‐Hennig, Ralf Wagner	11
16	A quasi-lentiviral green fluorescent protein reporter exhibits nuclear export features of late human immunodeficiency virus type 1 transcripts 2006 ·Virology ·Marcus Graf, Christine Ludwig, (unknown), (unknown), Ralf Wagner	12
17	Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus 2006 ·Virology ·Seraphin Kuate, Christiane Stahl‐Hennig, Heribert Stoiber, Godwin Nchinda, (unknown), (unknown), Ulrike Sauermann, (unknown), Ludwig Deml, Ralf Ignatius, Steve Norley, Paul Rácz, Klara Tenner‐Racz, Ralph M. Steinman, Ralf Wagner, Klaus Überla	40
18	Contribution of the Gag-Pol transframe domain p6* and its coding sequence to morphogenesis and replication of human immunodeficiency virus type 1 2004 ·Virology ·Christina Paulus, Christine Ludwig, Ralf Wagner	22
19	Identification of a Region in the Pr55gag-Polyprotein Essential for HIV-1 Particle Formation 1993 ·Virology ·A. von Poblotzki, Ralf Wagner, Matthias Niedrig, (unknown), (unknown), Susanne Modrow	80
20	Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses 1993 ·Journal of General Virology ·Ralf Wagner, (unknown), Ludwig Deml, Susanne Modrow, Hans Wolf	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact